Yoshiteru Oshima Selected Research

Yoshiteru Oshima Research Topics

Disease

10	Neoplasms (Cancer) 01/2021 - 12/2006
5	Malaria 10/2017 - 06/2002
5	Infections 01/2017 - 11/2004
3	Inflammation (Inflammations) 12/2021 - 01/2017
3	Astrocytoma (Pilocytic Astrocytoma) 08/2009 - 10/2005
3	Leukemia 12/2008 - 06/2004
2	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2015
2	Toxoplasmosis 10/2017 - 05/2015
2	Neoplasm Metastasis (Metastasis) 10/2016 - 08/2015
2	Carcinoma (Carcinomatosis) 10/2016 - 01/2014
2	Body Weight (Weight, Body) 06/2016 - 10/2008
2	Obesity 01/2015 - 10/2008
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2013 - 02/2009
1	Gram-Positive Bacterial Infections 12/2021
1	Tuberculosis (Tuberculoses) 10/2019
1	Granuloma 10/2019
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Hypoxia (Hypoxemia) 01/2019
1	Pulmonary Hypertension 01/2019
1	Parkinson Disease (Parkinson's Disease) 01/2019
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019
1	Proteostasis Deficiencies 01/2019
1	Triple Negative Breast Neoplasms 01/2019
1	Leishmaniasis 10/2017
1	Cryptosporidiosis 10/2017
1	Coccidiosis 10/2017
1	Starvation 01/2017
1	Dengue (Dengue Fever) 01/2017
1	Lung Neoplasms (Lung Cancer) 10/2016
1	Aortic Valve Stenosis (Aortic Stenosis) 05/2016
1	Pathologic Constriction (Stenosis) 05/2016
1	Immune System Diseases (Immune Disorders) 04/2016
1	Atopic Dermatitis (Atopic Eczema) 04/2016
1	Gram-Negative Bacterial Infections 09/2015
1	Osteosarcoma (Osteogenic Sarcoma) 08/2015
1	Weight Gain 01/2015
1	Chromosome Breakage 01/2012

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 04/2020 - 01/2017
5	brefelamideIBA 04/2020 - 10/2005
4	febrifugineIBA 01/2017 - 06/2002
4	Antimalarials (Antimalarial Agents)IBA 05/2015 - 06/2002
3	OsteopontinIBA 10/2019 - 10/2016
3	prolyl T RNA synthetaseIBA 10/2017 - 12/2014
3	halofuginoneIBA 01/2017 - 12/2014
3	Glucose (Dextrose)FDA LinkGeneric 12/2008 - 07/2007
2	Messenger RNA (mRNA)IBA 04/2020 - 01/2017
2	Blood Glucose (Blood Sugar)IBA 06/2016 - 10/2008
2	Peptidoglycan (Murein)IBA 08/2008 - 11/2004
2	EmeticsIBA 09/2003 - 06/2002
1	Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA 12/2021
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 12/2021
1	NF-kappa B (NF-kB)IBA 12/2021
1	Blocking AntibodiesIBA 01/2021
1	AmidesIBA 04/2020
1	Interleukin-2 (IL2)IBA 04/2020
1	Immune Checkpoint InhibitorsIBA 04/2020
1	Neuroprotective AgentsIBA 01/2019
1	Dictyostelium Differentiation-inducing factor-1IBA 01/2019
1	HalogensIBA 01/2019
1	Estrogen ReceptorsIBA 01/2019
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2019
1	CytokinesIBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	AA amyloidosisIBA 01/2019
1	Amino Acids FDA Link 01/2017
1	Therapeutic UsesIBA 01/2017
1	Ether (Diethyl Ether)IBA 01/2017
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2017
1	Thomsen-Friedenreich antibodiesIBA 01/2017
1	Phosphates (Orthophosphate)IBA 05/2016
1	Ointments (Pastes)IBA 04/2016
1	Immunoglobulin E (IgE)IBA 04/2016
1	Antimicrobial PeptidesIBA 09/2015
1	lysophosphatidic acidIBA 08/2015
1	Br-DIF-1IBA 08/2015
1	EnzymesIBA 05/2015
1	Cyclin D1IBA 01/2015
1	Estrogens (Estrogen)FDA Link 01/2015
1	Epidermal Growth Factor (EGF)IBA 01/2015
1	AcidsIBA 01/2015
1	ProlactinIBA 01/2015
1	Neuregulin-1 (Neuregulin 1)IBA 01/2015
1	p21-Activated KinasesIBA 01/2015
1	compound 18IBA 01/2015
1	Interleukin-8 (Interleukin 8)IBA 01/2014
1	4,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA 01/2013
1	satratoxin HIBA 01/2012
1	Methanol (Carbinol)IBA 07/2011
1	AntioxidantsIBA 07/2011
1	AcetoneIBA 09/2010
1	ErbB Receptors (EGF Receptor)IBA 08/2009
1	Chemokine ReceptorsIBA 02/2009
1	CD4 Antigens (CD4 Antigen)IBA 02/2009

Therapy/Procedure

3	Therapeutics 10/2016 - 02/2009
2	Immunotherapy 01/2021 - 04/2020
1	Drug Therapy (Chemotherapy) 01/2019
1	Radiotherapy 01/2017
1	Oral Administration 06/2016
1	Organ Transplantation 04/2016